Guideline

Shared Care Guidelines: Use of Gonadotrophin Releasing Hormone (GnRH) Agonists - Triptorelin

Read time: 1 mins

Last updated:1st Apr 2021

Source: British Society for Paediatric Endocrinology and Diabetes (BSPED)

Status: Live

Shared Care Guidelines: Use of Gonadotrophin Releasing Hormone (GnRH) Agonists - Triptorelin - British Society for Paediatric Endocrinology and Diabetes (BSPED)

Treatment with GnRH agonists should always be initiated and monitored by a specialist (Consultant Paediatric Endocrinologist or Consultant Paediatrician with expertise in growth disorders) as recognised by the British Society for Paediatric Endocrinology and Diabetes (BSPED).

Read full Guideline